HEPATITIS C VIRUS CHRONIC INFECTION

Infectious Diseases
2
Pipeline Programs
1
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
2100%

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Atea Pharmaceuticals
2 programs
2
Bemnifosbuvir-RuzasvirPhase 3Small Molecule1 trial
Bemnifosbuvir-RuzasvirPhase 3Small Molecule1 trial
Active Trials
NCT07037277RecruitingEst. Mar 2027
NCT06868264Active Not RecruitingEst. Dec 2026

Trial Timeline

Clinical trial activity over time

2025
2026
2027
Atea PharmaceuticalsBemnifosbuvir-Ruzasvir
Atea PharmaceuticalsBemnifosbuvir-Ruzasvir

Clinical Trials (2)

NCT07037277Atea PharmaceuticalsBemnifosbuvir-Ruzasvir

C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV

Start: Jun 2025Est. completion: Mar 2027
Phase 3Recruiting
NCT06868264Atea PharmaceuticalsBemnifosbuvir-Ruzasvir

C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV

Start: Apr 2025Est. completion: Dec 2026
Phase 3Active Not Recruiting

Related Jobs in Infectious Diseases

Senior Recruiter

Invivyd
New Haven, CT (Northeast preferred)
7h ago
$120K - $160K/yr

Senior Associate Scientist (contract), Upstream Polysaccharide Process Development

VaxCyte
San Carlos, California, United States
9h ago
$56/hr

Senior Associate Scientist (contract), Polysaccharide Analytical Development

VaxCyte
San Carlos, California, United States
10h ago
$56/hr

Director, Program Management

Metaphore Biotechnologies
Somerville, MA USA
13h ago
$179K - $237K/yr

Technician, Operations, DSP/ Technicien(ne) des opérations, DSP

Verona Pharma
CAN - Prince Edward Island - Charlottetown
Yesterday
$47K - $79K/yr

HVAC Maintenance Technician

Verona Pharma
USA - Delaware - Millsboro (Intervet)
Yesterday

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials
1 companies competing in this space

Related Indications

HIV Infections(449)COVID-19(223)Hepatitis C(191)Influenza(173)HIV(138)HIV-1-infection(115)Hepatitis C, Chronic(94)Chronic Hepatitis B(93)Chronic Hepatitis C(91)Covid19(79)